NCT03926962View on ClinicalTrials.gov

The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

March 14, 2013

Primary Completion Date

June 25, 2013

Study Completion Date

July 13, 2013

Conditions
Healthy
Interventions
DRUG

WCK 4873

100 to 1200 mg in tablets (the 100 mg dose cohort will receive half a tablet; higher dose cohorts will receive 1 or more tablets)

DRUG

Placebo Oral Tablet

Visually matching placebo

Sponsors

Lead Sponsor

Wockhardt
All Listed Sponsors
lead

Wockhardt

INDUSTRY

NCT03926962 - The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter